ArticleBMC public health2026
"With a little help from my friends" - collaborating with community experts to improve sampling and obtain a high response rate for a statewide naloxone availability survey.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating demographic variation in no-cost naloxone distribution in North Carolina: a cross-sectional survey study.Harm reduction journal · 2026Article
- Examining geographic disparities in access to no-cost naloxone in North Carolina: A cross-sectional survey of naloxone distribution programs.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundResearch and advocacy emphasize the importance of naloxone saturation not just in terms of how much naloxone is distributed but also to whom, by whom, and how it is distributed. Given the nuanced ways in which naloxone is distributed, community experts involved with naloxone distribution and harm reduction work can help researchers better assess naloxone availability. The objective of this paper is to describe collaborating with community experts to obtain a diverse sample and high response rate of a statewide survey investigating community-based naloxone availability.
methodsThis survey is part of a larger study that aims to develop and disseminate visual tools, such as a website with coverage maps to show naloxone sources, availability, and associated cost by county. Community experts, consisting of advisory board members and experts on the study team, represented the different constituencies from which study data would be sampled and for their expertise on community harm reduction work. Surveys were sent to individuals if they were identified as a representative of a program believed to potentially distribute naloxone at no-cost to community members in NC by the study team or community advisory board. Data collection occurred over the course of 8 months (June 2023-January 2024) and consisted of emails, phone calls, and mailers.
resultsThe overall response rate was 81.4%. In collaboration with community experts, the study team surveyed eight additional program types from the original sample list. Community experts helped identify contact information for program types and participated in triangulation during data cleaning. Four out of five program types with response rates above 80% had received personalized emails from a community expert.
conclusionsCommunity experts informed decision-making on survey design, sampling, survey distribution, and data cleaning processes for a survey designed to identify community-based sources of no-cost naloxone across NC. The immense contributions of the community experts for this statewide survey, which we are confident improved our sample, also likely increased the survey response rate. This underscores the importance of engaging community members in every step of research to produce relevant and meaningful outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.